ARTICLE

FindCenter AddIcon

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

By Steph Yin — 2020

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

Read on whyy.org

FindCenter Post-Image

Seismic Sisters: Fighting Stigma of Psychedelics with Science - An Interview with Natalie Ginsberg, Policy and Advocacy Director at Multidisciplinary Association for Psychedelic Studies

Society has started to become more accepting of our work and MAPS’ goal of mainstreaming psychedelic medicine seems closer than ever to being achieved,” explains MAPS Policy and Advocacy Director Natalie Ginsberg, M.S.W., in an interview with Jessica Semaan of Seismic Sisters.

Article
Jessica Semaan
2020
FindCenter AddIcon
FindCenter Post-Image

5 Women in Psychedelics You Should Know About

Badass women making waves in the psychedelic movement, from research to drug policy reform.

Article
Michelle Janikian
2019
FindCenter AddIcon
FindCenter Post-Image

In a Traumatised World, is Psychedelic Therapy our Best Hope for Change?

Could there be one factor that links together conflict, climate change, racism, anxiety and eating disorders?

Article
Kate Thompson
FindCenter AddIcon

EXPLORE TOPIC

MDMA